It remains to be investigated how these results relate to chronic thromboembolus formation, however, further investigations focusing on HGF/ Met may provide novel diagnostic and therapeutic tools that may be used in the treatment of patients with CTEPH. The gene discussed is HGF; the disease is chronic thromboembolic pulmonary hypertension.